Does PlexusDx offer different starting doses to reduce nausea risk
There are no monthly subscriptions or extra fees
The future of weight management and SWMPs As obesity continues to prevail, even as GLP-1s grow in popularity, individuals will continue to seek various weight management and obesity treatment options, ranging from diet food and drinks to health clubs and medical interventions
Patients have reported both positive and negative mood alterations
While their main role remains in diabetes treatment, certain GLP-1 therapies are also approved for weight management in individuals with obesity or overweight with comorbidities, given their modest but clinically meaningful effects on appetite regulation and body weight 2 , 6 , 7
The clinical data showed the 4 mg group achieving 17.1% body weight reduction at 48 weeks, which already exceeds what most single-receptor GLP-1 agonists deliver at their maximum doses